Evidence map›Paper›PMID 40231103›Full record

ArticleHeart rhythm O22025

Impact of atrial functional substrate in patients with atrial fibrillation: The potential utility of decremental evoked potential mapping in the atrium.

Yasuhito Kotake, Fumiyasu Hirano, Shunsuke Kawatani, Aiko Takami, Takuya Tomomori, Akihiro Okamura, Masaru Kato, Kazuhiro Yamamoto

Abstract read
In one paragraph

Article in Heart rhythm O2, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yasuhito KotakeDepartment of Cardiovascular Medicine, Endocrinology and Metabolism, Faculty of Medicine, Tottori University, Yonago, Japan.
Fumiyasu HiranoDepartment of Cardiovascular Medicine, Endocrinology and Metabolism, Faculty of Medicine, Tottori University, Yonago, Japan.
Shunsuke KawataniDepartment of Cardiovascular Medicine, Endocrinology and Metabolism, Faculty of Medicine, Tottori University, Yonago, Japan.
Aiko TakamiDepartment of Cardiology, Tottori Prefectural Central Hospital, Tottori, Japan.
Takuya TomomoriDepartment of Cardiovascular Medicine, Endocrinology and Metabolism, Faculty of Medicine, Tottori University, Yonago, Japan.
Akihiro OkamuraDepartment of Cardiovascular Medicine, Endocrinology and Metabolism, Faculty of Medicine, Tottori University, Yonago, Japan.
Masaru KatoDepartment of Cardiovascular Medicine, Endocrinology and Metabolism, Faculty of Medicine, Tottori University, Yonago, Japan.
Kazuhiro YamamotoDepartment of Cardiovascular Medicine, Endocrinology and Metabolism, Faculty of Medicine, Tottori University, Yonago, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Decremental evoked potential (DEEP) is one of the functional substrates mainly used in the field of ventricular arrhythmias, which is suggested to be a critical target of reentrant ventricular tachycardia. Objective: The purpose of this study is to investigate the characteristics of patients with atrial functional substrates expressed by DEEP and their clinical significance. Methods: Patients presenting for atrial fibrillation (AF) ablation from April 2023 to March 2024 at Tottori University Hospital were analyzed. After cryoballoon pulmonary vein isolation, DEEP was evaluated at the left atrial roof and posterior wall by extrastimulus pacing maneuvers. To verify the clinical significance of atrial DEEP, the relationship between atrial DEEP and various clinical valuables including the pericardial fat volume and clinical outcomes was assessed. Results: A total of 102 patients were included and 45% had persistent AF. Fifty-three percent of patients exhibited DEEP properties. DEEP was more prevalent in patients with persistent AF (61% vs 39%, Conclusion: This study demonstrated a correlation between atrial DEEP and longer duration of AF, higher brain natriuretic peptide levels, greater pericardial fat volume, and more early AF recurrence, suggesting that DEEP reflects a certain aspect of atrial electrophysiological remodeling and is a potential ablation target for AF.

Indexed as

Atrial fibrillationDecremental evoked potentialElectrophysiological remodelingFunctional substratePericardial fat volume

Identifiers

PMID40231103
PMCPMC11993794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.